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ABSTRACT Autoimmune subepidermal bullous diseases (AISBDs) exhibit 
various clinical presentations, histological appearances, prognoses, and 
responses to treatment. Many diagnostic techniques, such as direct immu-
nofluorescence (IF), indirect salt-split skin IF, and enzyme-linked immuno-
sorbent assays, are used in the differential diagnoses of AISBDs. However, 
these techniques require fresh frozen tissue, expensive laboratory equip-
ment, and sophisticated laboratory techniques. The purpose of this study 
was to evaluate the value of type IV collagen immunohistochemical (IHC) 
staining for the differential diagnosis of AISBDs. Paraffin-embedded blocks 
of skin biopsies were selected from 28 patients with autoimmune subepi-
dermal bullous diseases. Among these 28 cases, 24 patients exhibited bul-
lous pemphigoid (BP), 2 exhibited epidermolysis bullosa acquisita (EBA), 1 
exhibited linear immunoglobulin A dermatosis (LAD), and 1 exhibited bul-
lous systemic lupus erythematosus (BSLE). Sections were stained for type IV 
collagen and examined to determine the location of type IV collagen in the 
subepidermal blister. Type IV collagen positivity was observed on the base 
of the subepidermal blister in patients with BP (24 of 24 cases) and LAD (1 
of 1 case). Staining was observed on the roof of the blister in patients with 
EBA (2 of 2 cases) and BSLE (1 of 1 case), and irregular staining was also 
observed on the base in patients with EBA. In conclusion, type IV collagen 
IHC staining is a simple and useful diagnostic technique for the differential 
diagnosis of AISBDs.
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INTRODUCTION
Autoimmune bullous diseases are a heteroge-
neous group of disorders caused by circulating au-
toantibodies against distinct adhesion molecules of 
the skin. Among them, diseases that form blisters on 
the dermo-epidermal junction and produce auto-
antibodies to hemidesmosomal components in the 
epidermal basement membrane zone are called au-
toimmune subepidermal bullous disorders (AISBDs) 
and include bullous pemphigoid (BP), linear IgA der-
matosis (LAD), epidermolysis bullosa acquisita (EBA), 
and bullous systemic lupus erythematosus (BSLE). 
Providing a specific diagnosis is important due to the 
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variable prognoses and responses to treatments of 
these diseases. However, as they are very similar in 
terms of clinical symptoms and histopathological 
findings, these diseases often pose a major diagnos-
tic challenge (1). Many diagnostic techniques are em-
ployed to differentiate AISBDs, such as direct and in-
direct immunofluorescence (IF), immunoelectron mi-
croscopy, and enzyme-linked immunosorbent assays 
(ELISAs) (1). However, these techniques require fresh 
frozen tissues, expensive laboratory equipment, and 
sophisticated laboratory processes. Type IV collagen 
is the primary collagen found in extracellular base-
ment membranes and is a major component of the 
dermal-epidermal junction, where it is mostly found 
in the lamina densa. Accordingly, its location can be 
classified as the roof or base according to the sepa-
ration plane of AISBDs, which may be helpful for the 
differential diagnosis of these diseases (2-6). In this 
study, we evaluated the value of type IV collagen im-
munohistochemical (IHC) staining of formalin-fixed, 
paraffin-embedded (FFPE) tissue sections for the dif-
ferential diagnosis of AISBDs. 
METHODS
Subjects 
This study was approved by the Inje University Ilsan 
Paik Hospital Institutional Review Board Committee. 
We retrospectively reviewed patients diagnosed with 
AISBDs with subepidermal blisters between January 
2008 and December 2014 in the Department of Der-
matology, Inje University Ilsan Paik Hospital and Ewha 
University Mokdong Hospital using hematoxylin and 
eosin (H&E)-stained slides of skin biopsy specimens. 
The patients were diagnosed with AISBDs based on 
clinical symptoms, histopathological findings, and the 
results of direct IF. BP was diagnosed on the basis of 
clinically pruritic tense blisters without mucosal ero-
sion, scars or milia, histological evidence of bullous 
pemphigoid with linear deposits of immunoglobulin 
G (IgG), and/or complement 3 (C3) at the dermal-epi-
dermal junction by direct IF. LAD was diagnosed on 
the basis of histopathologic findings and linear depos-
its of immunoglobulin A (IgA) at the dermal-epidermal 
junction by direct IF with proper clinical features. The 
diagnosis of EBA was established by typical clinical 
findings such as blisters and erosions on mucocutane-
ous areas and dystrophic changes, such as milia, atro-
phic scars, nail deformities, and histological evidence 
of subepidermal blisterings with various inflammatory 
cell infiltration. Direct IF was performed on one patient 
with EBA. Diagnosis of BSLE was established on the ba-
sis of clinical findings and histological evidence of sub-
epidermal blisters with prominent neutrophil infiltra-
tion and mucin deposit in the dermis in a patient with 
known systemic lupus erythematosus. The research 
subjects included 24 patients with BP, 2 patients with 
EBA, 1 patient with BSLE, and 1 patient with LAD. 
IHC staining 
IHC staining for type IV collagen expression was 
performed in FFPE tissue sections using a BenchMark 
XT automated slide stainer (Ventana Medical Systems, 
Inc., Tucson, AZ, USA) according to the manufacturer’s 
instructions. FFPE tissue from the subject was sliced 
in 4 μm thick sections. Briefly, the sections were first 
deparaffinized and rehydrated, and endogenous per-
oxidase activity was quenched with hydrogen perox-
ide. The slide was immersed in a container filled with 
citrate buffer (pH 6.0) and heated for 5 minutes in a 
microwave oven. It was then cooled at room temper-
ature for 20 minutes. A primary anti-type IV collagen 
mouse monoclonal antibody (Leica Biosystems, New-
castle, UK: PHM-12) was applied at a dilution of 1:100 
for 60 minutes at 25 °C. An Ultra-View™ Universal DAB 
detection kit (Ventana Medical Systems Inc., Tucson, 
AZ, USA) was used for visualization of antibody reac-
tions. IHC-stained sections were examined to deter-
mine the location of collagen IV at the blister sites by 
one dermatologist and one dermatopathologist. The 
location of type IV collagen was classified as the roof 
and/or base for all of the subepidermal blisters. 
RESULTS
In all cases, positive staining for type IV collagen 
was observed in the basement membrane underly-
ing the epidermis and surrounding the blood ves-
sels and skin appendages (Figure 1). Type IV collagen 
positivity was observed on the blister bases for all 24 
cases of BP (Figure 2. a) and the one case of LAD (Fig-
ure 2. b). For the 2 cases of EBA (Figure 3. a), apparent 
linear staining was observed on the roof, but irregular 
staining was also observed on the base. In the patient 
with BSLE, apparent linear staining was observed on 
the roof of the blister but not on the base (Figure 3. 
b), (Table 1).
Figure 1. Type IV collagen immunohistochemical staining 
in the basement membrane of vessels and eccrine glands.
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Table 1. The results of direct immunofluores-
cence and immunolocalization of type IV colla-




Location of type 
IV collagen IHC 
staining
IgG IgA C3 Floor Roof
BP1 - - + + -
BP2 + - + + -
BP3 - N/A + + -
BP4 + N/A + + -
BP5 + N/A + + -
BP6 - N/A + + -
BP7 + N/A + + -
BP8 + N/A + + -
BP9 + N/A + + -
BP10 + N/A + + -
BP11 + N/A - + -
BP12 + - + + -
BP13 + N/A - + -
BP14 - N/A + + -
BP15 + - N/A + -
BP16 - - + + -
BP17 _ _ + + -
BP18 + - + + -
BP19 - - + + -
BP20 + - + + -
BP21 + N/A + + -
BP22 + - + + -
BP23 + - + + -
BP24 + - + + -
LAD - + - + -
EBA1 + - + irregular +
EBA2 N/A N/A N/A irregular +
BSLE N/A N/A N/A - +
BP: bullous pemphigoid; BSLE: Bullous systemic lupus 
erythematosus; C3: Complement 3; EBA: Epidermolysis bul-
losa acquisita; LAD: Linear immunoglobulin A dermatosis; 
IgA: Immunoglobulin A; IgG: Immunoglobulin G; +: Positive 
reactivity; -: Negative reactivity, N/A: Not available
Figure 2. (a, b) Type IV collagen immunohistochemical 
staining in the floor of subepidermal blisters from patients 
with bullous pemphigoid (A×200) and linear immunoglob-
ulin A dermatosis (B ×200).
Figure 3. (a, b) Type IV collagen immunohistochemical 
staining in epidermolysis bullosa acquisita patients showing 
linear staining on the roof and irregular staining on the base 
of a blister (A ×100). Linear staining is observed on the roof 
in bullous systemic lupus erythematosus patients (B ×100).
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DISCUSSION
AISBDs are potentially life-threatening skin dis-
eases, clinically characterized by blisters and erosions 
on the skin and mucous membranes. AISBDs are clas-
sified based on clinical, histopathological, and immu-
nological criteria. However, they are sometimes very 
similar in terms of clinical symptoms and histopatho-
logical findings, and these diseases often pose a major 
diagnostic challenge (1). BP is caused by autoantibod-
ies directed against two hemidesmosomal antigens, 
bullous pemphigoid antigen 1 (BPAG1) and bullous 
pemphigoid antigen 2 (BPAG2). Histopathologically, 
it is characterized by subepidermal separation at the 
dermo-epidermal junction and an inflammatory cell 
infiltration that tends to be rich in eosinophils inside 
of blisters and the upper dermis. Using direct IF, con-
tinuous linear deposition of IgG and/or C3 can be 
observed along the dermo-epidermal junction (1,7). 
In LAD, neutrophils mainly infiltrate at the tip of the 
papillary dermis with subepidermal blister formation. 
Direct IF reveals a homogeneous linear pattern of IgA 
deposition along the basement membrane zone (1,7). 
In patients with BSLE, subepidermal splitting and pap-
illary microabscesses resembling dermatitis herpeti-
formis (DH) have been observed. Direct IF often shows 
linear or granular IgG, IgA, IgM, or C3 deposition along 
the dermo-epidermal junction, and antibodies to type 
VII collagen have been detected in several patients (8). 
EBA is a disease that is caused by IgG autoantibodies 
against type VII collagen, a main component in an-
choring fibrils below the lamina densa of the base-
ment membrane (1,3). EBA is clinically and histopath-
ologically indistinguishable from BP. These conditions 
may be distinguished using indirect IF (with salt-split 
skin as a substrate), ELISAs, Western immunoblotting 
of both epidermal and dermal extracts, and direct im-
munoelectron microscopy studies. However, indirect 
IF requires fresh frozen tissue and is difficult to stan-
dardize. Immunoblotting and immunoprecipitation 
can also be used to identify the target antigens. How-
ever, they are both time-consuming qualitative tech-
niques. ELISA is a sensitive method for the diagnosis 
of these conditions and can be completed within one 
day. However, it requires sophisticated laboratory pro-
cessing and specific equipment (1,9,10).
Type IV collagen consists of 6 α-chain polypeptides 
and is a major component of the basement mem-
brane zone, where it forms the lamina densa of the 
hemidesmosome together with laminin and nidogen. 
Basement membrane zones are widely distributed in 
extracellular matrices that interface with the basilar 
portion of epithelial and endothelial cells and sur-
round muscle, adipose, and Schwann cells. Addition-
ally, type IV collagen is important in wound healing 
and in embryogenesis (7,10).
In this study, we performed type IV collagen IHC 
staining to differentiate AISBDs. In BP, because au-
toantibodies bind to BPAG1 and BPAG2, hemides-
mosomal protein and type IV collagen of the lamina 
densa should be found at the base of the blister when 
subepidermal blistering occurs (Fig. 4) (4-7,11). In LAD, 
subepidermal blisters are formed by separation at the 
lamina lucida above lamina densa, and similar to BP, 
type IV collagen positivity is found on the base of the 
blister (Figure 4) (4-7,11). In contrast, in EBA and BSLE, 
subepidermal blistering occurs due to autoantibod-
ies against type VII collagen, an exclusive component 
of anchoring fibrils that forms loops originating and 
terminating in the lamina densa. Therefore, the bind-
ing of autoantibodies to their target, type VII collagen, 
results in the separation of dermal anchoring fibrils 
from the lamina densa, and type IV collagen positiv-
ity may be found at the roof of the blister (Figure 5) 
(4-7,11,12).
Figure 5. Schematic model of a subepidermal blister in 
epidermolysis bullosa acquisita and bullous systemic lupus 
erythematosus patients.
Figure 4. Schematic model of a subepidermal blister in bul-
lous pemphigoid and linear immunoglobulin A dermatosis 
patients.
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In this study of 28 patients, all cases of BP (24 cas-
es) and LAD (1 case) showed apparent linear staining 
of type IV collagen on the base of blisters. For BSLE (1 
case), linear staining was observed on the roof of sub-
epidermal blisters. However, in patients with EBA (2 
cases), linear staining was observed on the roof of the 
blister and irregular staining was also observed on 
the base, which was different from BP which showed 
linear staining only on the base in all cases. Pardo et 
al. (4) conducted type IV collagen IHC staining using 
FFPE tissue for 45 cases of subepidermal blistering. 
Their results showed that linear staining was observed 
on the base of blisters in patients with BP, dermatitis 
herpetiformis, and porphyria cutanea tarda. Howev-
er, for patients with EBA, type IV collagen staining was 
observed on the roof of blisters. In a study of dog skin 
tissue by Olivry et al. (5) in 14 cases of EBA, 6 cases 
showed type IV collagen staining on the roof of blis-
ters, 4 cases showed staining on the base, and 4 cases 
showed staining on both sides of blisters. In contrast, 
in 21 cases of subepidermal bullous diseases other 
than EBA, no case showed staining on the roof alone. 
The presence of type IV collagen above subepider-
mal clefts exhibited a sensitivity of 71%, a specificity 
of 90%, and a positive predictive value and accuracy 
of 83% for the diagnosis of canine EBA. Thus, colla-
gen staining was reported to be a less expensive and 
more useful and convenient method than other diag-
nosis methods. In some cases of EBA, type IV collagen 
positivity was observed on both sides of subepider-
mal blisters. Based on this result, some authors have 
suggested that type IV collagen may be proteolyzed 
by inflammatory cells (4,6,13) and exhibit a separa-
tion within the lamina lucida, most likely reflecting 
the formation of a subepidermal blister at the locus 
minoris resistentiae (14). Nonetheless, when type IV 
collagen IHC staining is present on both the blister 
roof and floor, it will most often appear irregular and 
of varying intensity (perhaps digested) on the dermal 
side of the clefts (5), as also observed in our study.
Our study was limited by its retrospective nature 
and lack of comparison with results from indirect salt-
split IF or ELISA. Moreover, fewer cases of diseases 
other than BP were included due to their low preva-
lence rates. However, we confirmed the usefulness of 
type IV collagen IHC staining as a simple method with 
a high positive predictive value for the differential di-
agnosis of AISBDs.
CONCLUSION
We performed type IV collagen IHC staining using 
FFPE tissues from patients with AISBDs. Our results 
demonstrated that BP and LAD samples exhibited 
staining on the base of subepidermal blisters in all 
cases without staining on the roof, and BSLE samples 
showed staining on the roof of subepidermal blisters. 
EBA samples revealed linear positivity on the roof 
with irregular staining on the base of blister. Type IV 
collagen IHC staining has high sensitivity and speci-
ficity and can be used with FFPE tissue. In addition, 
this method does not require additional equipment 
and is simple and low cost. In conclusion, our study 
confirmed the value of type IV collagen IHC staining 
for the diagnosis of AISBDs, particularly for the differ-
entiation between BP and EBA. 
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